SJOGREN'S DISEASE

Clinical trials for SJOGREN'S DISEASE explained in plain language.

Never miss a new study

Get alerted when new SJOGREN'S DISEASE trials appear

Sign up with your email to follow new studies for SJOGREN'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1

Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.

Disease control Not yet recruiting

This phase 1 trial is testing an experimental drug called ATG-201 in adults with systemic lupus erythematosus, systemic sclerosis, or Sjögren's disease. ATG-201 is designed to bind to specific proteins on immune cells, potentially quieting the overactive immune response that driv…

Matched conditions: SJOGREN'S DISEASE

Phase: PHASE1 • Sponsor: Antengene Biologics Limited • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC

SJOGREN'S DISEASE

Get alerted when new SJOGREN'S DISEASE trials appear

Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.